¼¼°èÀÇ ÄÁ½Ã¾îÁö ÀÇ·á ½ÃÀå
Concierge Medicine
»óǰÄÚµå : 1739334
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,163,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,489,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÄÁ½Ã¾îÁö ÀÇ·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 381¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 214¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÄÁ½Ã¾îÁö ÀÇ·á ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 10.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 381¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±×·ì ¼ÒÀ¯´Â CAGR 11.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 288¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´Üµ¶ ¼ÒÀ¯ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 56¾ï ´Þ·¯, Áß±¹Àº CAGR 9.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÄÁ½Ã¾îÁö ÀÇ·á ½ÃÀåÀº 2024³â¿¡ 56¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 9.6%¸¦ ±â·ÏÇϸç 2030³â±îÁö 60¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 9.3%¿Í 8.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 7.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÄÁ½Ã¾îÁö ÀÇ·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÄÁ½Ã¾îÁö ÀÇ·á°¡ ÀÇ·á ¼­ºñ½º Á¦°ø °æÇèÀ» º¯È­½ÃŰ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÄÁ½Ã¾îÁö ÀÇ·á´Â ȯÀÚ¿¡°Ô ½Ã°£, Åõ¸í¼º, Á¢±Ù¼ºÀ» ¿ì¼±½ÃÇÏ´Â ÇÁ¸®¹Ì¾ö ÀÇ·á ¸ðµ¨À» Á¦°øÇÔÀ¸·Î½á ÀÇ·á Á¢±Ù¼º, °³ÀÎÈ­, ¼öÀÍÈ­ ¹æ½ÄÀ» ºü¸£°Ô ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ À¯·á Áø·á¿Í ´Þ¸® ÄÁ½Ã¾îÁö ÀÇ·á´Â ¸®Å×ÀÌ³Ê ±â¹Ý ¸ðµ¨·Î ¿î¿µµÇ¸ç, ȯÀÚ´Â ¿¬È¸ºñ ¶Ç´Â ¿ùȸºñ¸¦ ÁöºÒÇÏ´Â ´ë½Å Àǻ翡°Ô 24½Ã°£ 365ÀÏ Áø·á, ´çÀÏ ¿¹¾à, Àå½Ã°£ Áø·á, °íµµ·Î °³ÀÎÈ­µÈ Äɾî Ç÷£À» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¸ðµ¨Àº È¥ÀâÇÑ Áø·á¼Ò, ±ÞÇÏ°Ô ÀâÈù ¿¹¾à, ´ÜÆíÀûÀÎ Áø·á Á¶Á¤°ú °°Àº ¿À·£ ¹®Á¦¸¦ ÇØ°áÇϸç, °í¼ÒµæÃþ, ±â¾÷ ÀÓ¿ø, ¸¸¼ºÁúȯÀ» °ü¸®Çϴ ȯÀڵ鿡°Ô ƯÈ÷ ¸Å·ÂÀûÀÏ ¼ö ÀÖ½À´Ï´Ù.

±× ¸Å·ÂÀº ÆíÀǼº, ǰÁú, ÅëÁ¦·ÂÀ̶ó´Â °¡Ä¡ Á¦¾È¿¡ ÀÖ½À´Ï´Ù. ȯÀÚµéÀº Á¾Á¾ ´õ ±ä ¿¹¾à ½Ã°£, ¸ÂÃãÇü À£´Ï½º °èȹ, ¹®ÀÚ, À̸ÞÀÏ, ÅÚ·¹Çコ¸¦ ÅëÇØ Àǻ翡°Ô Á÷Á¢ ¿¬¶ôÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ¾ò°Ô µË´Ï´Ù. ÀÇ»çÀÇ °æ¿ì, ÀÌ ¸ðµ¨Àº ȯÀÚ ÆÐ³ÎÀ» Á¦ÇÑÇÏ°í º¸Çè »óȯ¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÃÖ¼ÒÈ­ÇÔÀ¸·Î½á ÀçÁ¤Àû ¿¹Ãø °¡´É¼º°ú °ü¸® ºÎ´ãÀ» ÁÙ¿©ÁÝ´Ï´Ù. ÀÌ ¶§¹®¿¡ ƯÈ÷ µµ½Ã¿Í ºÎÀ¯ÇÑ ±³¿Ü Áö¿ª¿¡¼­´Â ÁÖÄ¡ÀÇ, ³»°ú ÀÇ»ç, ½ÉÁö¾î Àü¹®ÀǵéÀÌ ÄÁ½Ã¾îÁö ¸ðµ¨·Î ÀüȯÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù.

ÄÁ½Ã¾îÁö ÀǷḦ Çâ»ó½ÃŰ´Â µðÁöÅÐ ¹× ÀÓ»ó Çõ½ÅÀ̶õ?

±â¼úÀº ±âÁ¸ ÇコÄɾî¿ÍÀÇ Â÷º°È­¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÄÁ½Ã¾îÁö Ç÷§ÆûÀº ÇöÀç EMR, ¿ø°Ý ¸ð´ÏÅ͸µ ±â±â, AI ±â¹Ý Áø´Ü µµ±¸, º¸¾È Ä¿¹Â´ÏÄÉÀÌ¼Ç Æ÷ÅÐÀ» °áÇÕÇÑ ÅëÇÕ µðÁöÅÐ °Ç°­ »ýŰ踦 Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀ» ÅëÇØ ÀÇ»ç´Â ½Ç½Ã°£ »ýü µ¥ÀÌÅ͸¦ ÃßÀûÇϰí, °Ç°­ À§ÇèÀ» »çÀü¿¡ °ü¸®Çϰí, Áö¼ÓÀûÀÎ Ä¡·á °³ÀÔÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. Ç÷¾Ð°è, ½ÉÀüµµ ÆÐÄ¡, Ç÷´ç ÃøÁ¤±â, ÇÇÆ®´Ï½º Æ®·¡Ä¿ µî ¿þ¾î·¯ºí ¹× Ä¿³ØÆ¼µå Çコ ±â±â´Â ¿¹¹æÀû Ä¡·á¿Í Á¶±â °³ÀÔ¿¡ µµ¿òÀÌ µÇ´Â µ¥ÀÌÅͰ¡ dzºÎÇÑ È¯ÀÚ ÇÁ·ÎÇÊÀ» ±¸ÃàÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

AI ±â¹Ý Áõ»ó °Ë»ç±â ¹× Áø´Ü µµ¿ì¹Ì°¡ ÄÁ½Ã¾îÁö ¾Û¿¡ ÅëÇÕµÇ¾î ¼±º° ¹× ÀÇ»ç°áÁ¤À» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀϺΠŬ¸®´Ð¿¡¼­´Â À¯Àüü ½ºÅ©¸®´×, Àå³» ¹Ì»ý¹° ºÐ¼®, ÈÄ»ýÀ¯ÀüÇÐÀû ÇÁ·ÎÆÄÀϸµÀ» Á¤±âÀûÀÎ Æò°¡¿¡ ÅëÇÕÇÏ¿© °³ÀÎÈ­µÈ ¿¹¹æ ÀÇ·áÀÇ »õ·Î¿î º¥Ä¡¸¶Å©¸¦ ±¸ÃàÇϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÇöÀç ±âÁؼ± À§Çèµµ ¸ÅÇÎÀ» ÅëÇØ À¯ÀüÀÚ ¹× ´ë»ç ÇÁ·ÎÇÊ¿¡ µû¸¥ ½Ä´Ü, »ýȰ½À°ü, Ä¡·á ¿ä¹ýÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

ÄÁ½Ã¾îÁö Ç÷§ÆûÀº ¶ÇÇÑ ´ë¸é Áø·á¿Í °¡»ó Áø·á, ¿ø°Ý Áø´Ü, ¸ð¹ÙÀÏ Ã¤Ç÷ ¼­ºñ½º¸¦ °áÇÕÇÑ ÇÏÀ̺긮µå Áø·á Á¦°ø ¸ðµ¨À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿È´Ïä³Î ÇÁ·¹ÀÓ¿öÅ©´Â ÀçÅÃÀÇ·á±â°ü, Áø´Ü ¿¬±¸¼Ò, ¿ø°ÝÀÇ·á Á¦°øÀÚ¿ÍÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼±ÁøÀûÀÎ ¸ðµ¨Àº ÄÁ½Ã¾îÁö ¼­ºñ½º¸¦ ±â¾÷ À£´Ï½º ÇÁ·Î±×·¥±îÁö È®ÀåÇÏ¿© °æ¿µÁø°ú °í¼º°ú ÆÀ¿¡°Ô ¹«Á¦ÇÑÀÇ °¡»ó ¶Ç´Â ÇöÀå ÀÇ·á »ó´ãÀ» Á¦°øÇÏ¿© Á÷Àå ³» °Ç°­ ÁõÁø°ú °á±Ù·ü °¨¼Ò¸¦ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ÁøÀÔ ±â¾÷ÀÇ ÁÖ¿ä ¸é¸é°ú °¢ °èÃþº° ¼ö¿ä ÃßÀÌ´Â?

ÄÁ½Ã¾îÁö ÀÇ·áÀÇ Ãʱ⠻ç¿ëÀÚÃþÀº ºÎÀ¯Ãþ°ú ±â¾÷ÀÇ °í±Þ Àü¹®Á÷ Á¾»çÀÚµéÀÌ ÁÖ¸¦ ÀÌ·ç¾úÀ¸³ª, ÇöÀç´Â Áß»êÃþ ÀºÅðÀÚ, ±â¼ú¿¡ ´ÉÅëÇÑ ¹Ð·¹´Ï¾ó ¼¼´ë, ´ÜÆíÀûÀÎ ÀÇ·á ¼­ºñ½º¿¡ ºÒ¸¸À» °¡Áø ¸¸¼ºÁúȯ ȯÀڵ鿡°Ôµµ °ü½ÉÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ´ë±â¾÷µéÀº ÀÔ¿ø °¨¼Ò, »ý»ê¼º Çâ»ó, ÀÎÀç È®º¸ µî ÅõÀÚ ´ëºñ È¿°ú¸¦ ÀνÄÇϰí Á÷¿ø º¹Áö ÇýÅÃÀÇ ÀÏȯÀ¸·Î ÄÁ½Ã¾îÁö ÀÇ·á ¼­ºñ½º¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

½ºÅ¸Æ®¾÷°ú Ç÷§Æû ±â¹Ý ÄÁ½Ã¾îÁö ÇÁ·¢Æ¼½º´Â ´Ù¾çÇÑ °èÃþÀ» À§ÇÑ Àú·ÅÇÑ ´Ü°èº° ¸ðµ¨À» ÅëÇØ ÀÌ ºÐ¾ß¿¡ ÁøÀÔÇϰí ÀÖ½À´Ï´Ù. ±¸µ¶·á´Â ´Ù¾çÇϸç, ±âº» ÆÐŰÁö´Â¿ù 50´Þ·¯ÀÇ °¡»ó Àü¿ë ¼­ºñ½º¿¡¼­ ½ÃÀÛÇÏ¿© ¼öõ ´Þ·¯¿¡ À̸£´Â ¿¤¸®Æ® ´ë»óÀÇ Ç® ½ºÆåÆ®·³ Äɾ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. ¼Ò¾Æ°ú ÄÁ½Ã¾îÁö Äɾî, ¿©¼º °Ç°­ Ŭ¸®´Ð, Àå¼ö Àü¹® ÄÁ½Ã¾îÁö Áø·á¼Òµµ µîÀåÇϰí ÀÖ¾î ¼ö¿äÀÇ ¼¼ºÐÈ­¿Í Á¦Ç°ÀÇ Àü¹®È­°¡ ÁøÇàµÇ°í ÀÖÀ½À» ¾Ë ¼ö ÀÖ½À´Ï´Ù.

Áö¸®ÀûÀ¸·Î´Â ͏®Æ÷´Ï¾Æ, ´º¿å, Ç÷θ®´Ù, ÅØ»ç½º¸¦ Áß½ÉÀ¸·Î ¹Ì±¹ÀÌ ¿©ÀüÈ÷ °¡Àå Å« ½ÃÀåÀÌÁö¸¸, ij³ª´Ù, ¿µ±¹, ¾Æ¶ø¿¡¹Ì¸®Æ®, µ¿³²¾Æ½Ã¾Æ¿¡¼­µµ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¸¹Àº ÇØ¿Ü ÁÖÀç¿ø, ÀæÀº ¿©ÇàÀÚ, µðÁöÅÐ ³ë¸¶µåµéÀº Àü ¼¼°è ¿ø°ÝÁø·á Áö¿ø ¹× ÀÇ·á ¼Ûȯ ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÄÁ½Ã¾îÁö Ç÷£À» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ¿ë·® Á¦¾à°ú ȯÀÚµéÀÇ ºÒ¸¸À» ÇØ°áÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ´Â °¡¿îµ¥, ÄÁ½Ã¾îÁö ÀÇ·á´Â °ø°ø ½Ã½ºÅÛ°ú ÃÊÆ¯±Þ ¹Î°£ º´¿ø »çÀÌÀÇ ÇÁ¸®¹Ì¾ö °ÝÂ÷¸¦ ¸Þ¿ì°í ÀÖ½À´Ï´Ù.

¼¼°è ÄÁ½Ã¾îÁö ÀÇ·á ½ÃÀå ±Þ¼ºÀå ¿øµ¿·ÂÀº?

ÄÁ½Ã¾îÁö ÀÇ·á ½ÃÀåÀÇ ¼ºÀåÀº ÀüÅëÀûÀÎ ÀÇ·á¿¡ ´ëÇÑ ºÒ¸¸, ¸¸¼ºÁúȯÀÇ È®»ê, ÀÇ·áÀÇ ¼ÒºñÀÚÈ­ °¡¼ÓÈ­¿¡ »Ñ¸®¸¦ µÐ ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °¡Àå °­·ÂÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â ´ë±Ô¸ð ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ÀüÅëÀûÀΠȯÀÚ-ÀÇ»ç °ü°èÀÇ Ä§½ÄÀÔ´Ï´Ù. Àǻ簡 ½Ã°£Àû Á¦¾à, ¼­·ù ÀÛ¾÷ÀÇ Áõ°¡, ȯÀÚ °úºÎÇÏ¿¡ Á÷¸éÇÔ¿¡ µû¶ó Ä¡·áÀÇ Áú°ú ¸¸Á·µµ°¡ ¶³¾îÁö°í ÀÖ½À´Ï´Ù. ÄÁ½Ã¾îÁö ¸ðµ¨Àº ½Ã°£, ½Å·Ú, Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇÔÀ¸·Î½á ÀÌ·¯ÇÑ °ü°è¸¦ ȸº¹ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀº Çö´ë ȯÀÚÀÇ µðÁöÅÐÈ­ÀÔ´Ï´Ù. ±â¼ú·Î °­È­µÈ ȯÀÚµéÀº 24½Ã°£ 365ÀÏ Á¢±Ù¼º, °³ÀÎÈ­µÈ Ä¡·á, µ¥ÀÌÅÍ ¼ÒÀ¯±ÇÀ» ¿ä±¸Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÄÁ½Ã¾îÁö ¸ðµ¨°ú º»ÁúÀûÀ¸·Î ÀÏÄ¡Çϴ Ư¡ÀÔ´Ï´Ù. ¶ÇÇÑ, ¿¹¹æÀÇÇÐ, À£´Ï½º ÃÖÀûÈ­, °Ç°­¼ö¸í ¿¬ÀåÀÌ °­Á¶µÇ¸é¼­ »çÀü ¿¹¹æÀû °Ç°­ ÃßÀû, ¿¬ 1ȸ °Ç°­°ËÁø, À¯ÀüÀÚ °Ë»ç, ¶óÀÌÇÁ½ºÅ¸ÀÏ ÄÚĪ µîÀ» ÀϰýÀûÀ¸·Î Á¦°øÇÏ´Â ÄÁ½Ã¾îÁö ¼­ºñ½ºÀÇ Åä¾çÀÌ ¸¶·ÃµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ÅõÀÚÀÚµéÀÇ °ü½É°ú Ç÷§Æû ÅëÇÕÀ¸·Î ÀÎÇØ ÀÌ ¸ðµ¨Àº È®ÀåµÇ°í ÀÖ½À´Ï´Ù. º¥Ã³ ijÇÇÅÐÀº È®Àå °¡´ÉÇÑ B2C ¹× B2B2C ¸ðµ¨À» Á¦°øÇÏ´Â µðÁöÅÐ ¿ì¼±ÀÇ ÄÁ½Ã¾îÁö ½ºÅ¸Æ®¾÷¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. º¸Çè»ç ¹× ÀÚÁ¶Àû °í¿ëÁÖµéÀº ÄÁ½Ã¾îÁö ±×·ì°ú Á¦ÈÞÇÏ¿© º¸Çè±Ý û±¸ ºñ¿ëÀ» Àý°¨ÇÏ°í ¼­ºñ½º ǰÁúÀ» °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­¿Í ¸¸¼ºÁúȯÀÇ ºÎ´ãÀ¸·Î ÀÎÇØ ÀÇ·áºñ ÁöºÒÀÇ Æ²ÀÌ °è¼Ó ¿Ö°îµÇ°í ÀÖ´Â °¡¿îµ¥, ÄÁ½Ã¾îÁö ÀÇ·á´Â ÀÓ»óÀû ¿ì¼ö¼º°ú ¼ÒºñÀÚ Áß½ÉÀÇ ¼­ºñ½º Á¦°øÀ» °áÇÕÇÑ ÇÏÀ̺긮µå ¿É¼ÇÀ¸·Î¼­ Àå±âÀûÀ¸·Î °­·ÂÇÑ ¼ºÀåÀÇ ¹ßÆÇÀ» ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¼ÒÀ¯ ÇüÅÂ(±×·ì, ´Üµ¶), ¿ëµµ(¼øÈ¯±â°ú, 1Â÷ Áø·á, Á¤½Å°ú, ¼Ò¾Æ°ú, Á¤°ñ, ½Å°æ°ú, ±âŸ ¿ëµµ), ÃÖÁ¾»ç¿ëÀÚ(°³ÀÎ, ±â¾÷ Á¶Á÷, Á¤ºÎ±â°ü)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ ÇÕ°è 42°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¸ÅÃâ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù : Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù : ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м®:

¹Ì±¹ <> Áß±¹ <> ¸ß½ÃÄÚ <> ij³ª´Ù <> EU <> ÀϺ» <> Àεµ <> ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ® : Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ® ±×·ìÀ» Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Concierge Medicine Market to Reach US$38.1 Billion by 2030

The global market for Concierge Medicine estimated at US$21.4 Billion in the year 2024, is expected to reach US$38.1 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Group Ownership, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$28.8 Billion by the end of the analysis period. Growth in the Standalone Ownership segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.6 Billion While China is Forecast to Grow at 9.6% CAGR

The Concierge Medicine market in the U.S. is estimated at US$5.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Concierge Medicine Market - Key Trends & Drivers Summarized

Why Is Concierge Medicine Transforming the Healthcare Delivery Experience?

Concierge medicine is rapidly redefining how healthcare is accessed, personalized, and monetized by offering patients premium care models that prioritize time, transparency, and access. Unlike traditional fee-for-service practices, concierge medicine operates on a retainer-based model, wherein patients pay annual or monthly membership fees in exchange for 24/7 access to physicians, same-day appointments, extended consultations, and highly personalized care plans. This model addresses long-standing issues such as overcrowded practices, rushed appointments, and fragmented care coordination, making it especially attractive to high-income individuals, corporate executives, and patients managing chronic conditions.

The appeal lies in its value proposition of convenience, quality, and control. Patients often receive longer appointment durations, customized wellness planning, and direct access to their physician via text, email, or telehealth-without the delays common in traditional care pathways. For physicians, the model provides financial predictability and reduced administrative burden by limiting patient panels and minimizing reliance on insurance reimbursements. This has led to a growing migration of primary care providers, internists, and even specialists toward concierge models, particularly in urban areas and affluent suburbs.

What Digital and Clinical Innovations Are Elevating Concierge Medical Practices?

Technology plays a pivotal role in differentiating concierge medicine from conventional healthcare. Concierge platforms now offer integrated digital health ecosystems that combine EMRs, remote monitoring devices, AI-based diagnostic tools, and secure communication portals. These platforms allow physicians to track real-time biometric data, proactively manage health risks, and offer continuous care interventions. Wearables and connected health devices-such as blood pressure cuffs, ECG patches, glucose monitors, and fitness trackers-are used to build data-rich patient profiles that inform preventive care and early interventions.

AI-powered symptom checkers and diagnostic assistants are embedded into concierge apps to support triaging and decision support. Some practices are integrating genomic screening, gut microbiome analysis, and epigenetic profiling into routine assessments, creating a new benchmark in personalized preventive medicine. Patients can now undergo baseline risk mapping and receive diet, lifestyle, and therapeutic regimens aligned to their genetic and metabolic profile.

Concierge platforms are also embracing hybrid care delivery models that merge in-person visits with virtual consultations, remote diagnostics, and mobile phlebotomy services. This omnichannel framework is being scaled via strategic partnerships with home health agencies, diagnostic labs, and telehealth providers. In some advanced models, concierge services are being extended to corporate wellness programs, offering executives and high-performing teams unlimited access to virtual or onsite medical consultations, enhancing workplace health and reducing absenteeism.

Who Are the Key Market Participants and How Is Demand Evolving Across Demographics?

While the initial user base of concierge medicine consisted largely of wealthy individuals and high-level corporate professionals, the model is now attracting interest from middle-income retirees, tech-savvy millennials, and chronically ill patients frustrated by fragmented care. Large employers are increasingly subsidizing concierge medicine access as part of their employee health benefits, recognizing the return on investment in reduced hospitalization, improved productivity, and talent retention.

Startups and platform-driven concierge practices are entering the space with affordable, tiered models that cater to different demographics. Subscription fees have diversified, with basic packages starting as low as $50/month for virtual-only services and extending into thousands of dollars for elite, full-spectrum care. Pediatric concierge care, women’s wellness clinics, and longevity-focused concierge practices are also emerging, indicating demand fragmentation and product specialization.

Geographically, the U.S. remains the largest market, particularly in California, New York, Florida, and Texas, while adoption is growing in Canada, the UK, UAE, and Southeast Asia. Many expats, frequent travelers, and digital nomads are opting for concierge plans that offer global teleconsultation support and medical repatriation services. As healthcare systems worldwide grapple with capacity constraints and patient dissatisfaction, concierge medicine is filling a premium gap between public systems and ultra-high-end private hospitals.

What Is Fueling the Surge in the Concierge Medicine Market Worldwide?

The growth in the concierge medicine market is driven by several factors rooted in dissatisfaction with conventional care, rising chronic disease prevalence, and the accelerating consumerization of healthcare. One of the most powerful drivers is the erosion of the traditional patient-physician relationship in large healthcare systems. As physicians face time constraints, increasing paperwork, and patient overload, the quality of care and satisfaction diminish. Concierge models restore that relationship by ensuring time, trust, and continuity of care.

Another significant driver is the digital fluency of modern patients. Empowered by technology, patients now demand 24/7 access, personalized care, and data ownership-features inherently aligned with concierge models. Additionally, the growing emphasis on preventive care, wellness optimization, and healthspan extension has created fertile ground for concierge services that offer proactive health tracking, annual physicals, genetic screenings, and lifestyle coaching as part of bundled offerings.

The model is also scaling due to investor interest and platform consolidation. Venture capital is pouring into digital-first concierge startups offering scalable B2C and B2B2C models. Insurance firms and self-funded employers are partnering with concierge groups to lower claims costs and enhance service quality. As reimbursement frameworks continue to strain under aging populations and chronic disease burdens, concierge medicine stands out as a hybrid alternative combining clinical excellence with consumer-centric service delivery-setting the stage for robust long-term growth.

SCOPE OF STUDY:

The report analyzes the Concierge Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Ownership (Group, Standalone); Application (Cardiology, Primary Care, Psychiatry, Pediatrics, Osteopathy, Neurology, Other Applications); End-User (Individuals, Corporate Organizations, Government Agencies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â